tiprankstipranks
Trending News
More News >
Protagenic Therapeutics (PTIX)
NASDAQ:PTIX
US Market

Protagenic Therapeutics (PTIX) Income Statement

Compare
91 Followers

Protagenic Therapeutics Income Statement

Last quarter (Q3 2025), Protagenic Therapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q3, Protagenic Therapeutics's net income was $-869.50K. See Protagenic Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -50.29K$ -28.22K$ -30.00$ 0.00$ -286.00
Operating Expenses
$ 5.70M$ 4.50M$ 3.56M$ 4.14M$ 2.55M
Depreciation and Amortization
$ 50.29K$ 28.22K$ 30.00$ 286.00$ 286.00
EBITDA
$ -5.47M$ -4.50M$ -3.42M$ -4.14M$ -2.55M
Operating Income
$ -5.70M$ -4.53M$ -3.56M$ -4.14M$ -2.55M
Other Income/Expenses
$ 175.61K$ -474.00K$ 2.28K$ -383.00K$ 2.88K
Pretax Income
$ -5.53M$ -5.00M$ -3.56M$ -4.52M$ -2.55M
Net Income
$ -5.53M$ -5.00M$ -3.56M$ -4.52M$ -2.55M
Per Share Metrics
Basic EPS
$ -1.13$ -1.15$ -0.82$ -1.24$ -1.00
Diluted EPS
$ -1.13$ -1.15$ -0.82$ -1.24$ -1.00
Weighted Average Shares Outstanding
4.90M 4.34M 4.32M 3.69M 2.58M
Weighted Average Shares Outstanding (Diluted)
4.90M 4.34M 4.32M 3.69M 2.58M
Currency in USD

Protagenic Therapeutics Earnings and Revenue History